CAT No: CP25535
CAS No: 197632-76-1
Synonyms/Alias: 197632-76-1;Fmoc-N-Me-Lys(Boc)-OH;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid;L-Lysine, N6-[(1,1-dimethylethoxy)carbonyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-N2-methyl-;N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-N2-methyl-L-lysine;Fmoc-Nalpha-methyl-Ne-t-Boc-L-lysine;(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid;(S)-2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)(Methyl)Amino)-6-(Tert-Butoxycarbonylamino)Hexanoic Acid;Fmoc-L-MeLys(Boc)-OH;(2S)-6-[(tert-butoxycarbonyl)amino]-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}hexanoic acid;Fmoc-MeLys(Boc)-OH;Fmoc-N-Me-L-Lys(Boc)-OH;MFCD04973182;Fmoc-N-Methyl-Lysine(Boc);SCHEMBL25354987;DTXSID40673999;BCP28353;AKOS015914407;HY-W036333;AS-17235;PD197081;CS-0089875;Fmoc-N-alpha-methyl-N-epsilon-t-Boc-L-lysine;S-197632-76-1;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-N-epsilon-t-butyl-oxycarbonyl-L-lysine;864-595-6;N~6~-(tert-Butoxycarbonyl)-N~2~-{[(9H-fluoren-9-yl)methoxy]carbonyl}-N~2~-methyl-L-lysine;
Chemical Name: N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-N-epsilon-t-butyloxycarbonyl-L-lysine
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C27H34N2O6 |
M.W/Mr. | 482.6 |
Sequence | Three Letter Code:Fmoc-N(Me)Lys(Boc)-OH |
Application | Peptide synthesis; Drug screening |
Size | 250 mg;1 g; |
InChI | InChI=1S/C27H34N2O6/c1-27(2,3)35-25(32)28-16-10-9-15-23(24(30)31)29(4)26(33)34-17-22-20-13-7-5-11-18(20)19-12-6-8-14-21(19)22/h5-8,11-14,22-23H,9-10,15-17H2,1-4H3,(H,28,32)(H,30,31)/t23-/m0/s1 |
InChI Key | JMBKBGOKNZZJQA-QHCPKHFHSA-N |
Canonical SMILES | CC(C)(C)OC(=O)NCCCCC(C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13 |
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.